J&J | JNJ - Betriebsergebnis

Aktienkurs
227.79
Täglich Wechseln
2.45 1.09%
Monatlich
-6.06%
Jährlich
46.10%
Q2 Prognose
222.63




Betriebsergebnis Veränderung Datum
AbbVie USD 5.81B 1.23B 2025-12
Abbott USD 1.85B 399M 2026-03
Amgen USD 3.96B 464M 2025-12
AstraZeneca USD 2.97B 4.48B 2025-12
Baxter International USD -214.2M 415.4M 2025-12
Bayer EUR 1.11B 1.65B 2025-12
Becton, Dickinson and Co. USD 663M 163M 2025-12
Biogen USD 659.6M 192.2M 2025-09
Boston Scientific USD 1.05B 190M 2026-03
Bristol-Myers Squibb USD 4.2B 562M 2025-12
CONMED USD 36.62M 24.74M 2025-12
Cooper Companies USD 212.8M 72.4M 2025-12
Dexcom USD 323M 80.5M 2025-12
Edwards Lifesciences USD 514.7M 144.4M 2026-03
Eli Lilly USD 8.99B 599.9M 2025-12
Gilead Sciences USD 2.96B 551M 2025-12
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
Globus Medical USD 181.31M 298.83M 2025-12
Insulet USD 146.3M 28.6M 2025-12
Integra LifeSciences USD 66M 54.24M 2025-12
Intuitive Surgical USD 859.7M 5.6M 2026-03
J&J USD 6.62B 1.03B 2026-03
Medtronic USD 1.74B 40M 2025-12
Merck USD 6.24B 318M 2025-12
Merit Medical Systems USD 54.2M 11.58M 2025-12
Novartis USD 4.06B 437M 2025-12
Pfizer USD 4.65B 3.99B 2025-12
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Roche Holding CHF 9.56B 3.8B 2025-12
Sanofi EUR 1.94B 239M 2026-03
Stryker USD 1.97B 609M 2025-12
Tandem Diabetes Care USD 8.29M 31.16M 2025-12
Teva Pharmaceutical Industries USD 487M 581M 2025-12
Vertex Pharmaceuticals USD 1.26B 24.5M 2025-12
Zimmer Biomet Holdings USD 302.9M 35.4M 2025-12
Zoetis USD 835M 101M 2025-12